Search by Drug Name or NDC

    NDC 68084-0776-01 Divalproex Sodium 250 mg/1 Details

    Divalproex Sodium 250 mg/1

    Divalproex Sodium is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is DIVALPROEX SODIUM.

    Product Information

    NDC 68084-0776
    Product ID 68084-776_05bc13a8-84ea-4f3d-e063-6294a90a9279
    Associated GPIs 72500010100610
    GCN Sequence Number 004539
    GCN Sequence Number Description divalproex sodium TABLET DR 250 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 17290
    HICL Sequence Number 001884
    HICL Sequence Number Description DIVALPROEX SODIUM
    Brand/Generic Generic
    Proprietary Name Divalproex Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Divalproex Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name DIVALPROEX SODIUM
    Labeler Name American Health Packaging
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090554
    Listing Certified Through 2024-12-31

    Package

    NDC 68084-0776-01 (68084077601)

    NDC Package Code 68084-776-01
    Billing NDC 68084077601
    Package 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-776-01) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (68084-776-11)
    Marketing Start Date 2015-03-02
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.1065
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DIVALPROEX SOD DR 250 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis